Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
96 participants
INTERVENTIONAL
2022-02-22
2022-04-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The survey form consists of 4 parts; descriptive general information,eating habits,Gastrointestinal Symptoms Rating Scale (GSRS) and the frequency of The consumption of particular food. In order to rate the gastrointestinal symptoms of the patients the GSRS scale which was validated and deemed reliable in Turkish will be used The foods that increase the frequency of gastrointestinal symptoms such as spicy foods,chocolate,Chips,carbonated drinks,citrus fruits are also questioned in terms of frequency of consumption.
In order to investigate the patients adherence to the study, reminders will be taking place by giving them a call two times a week. At the end of the intervention period,GSRS scale will be reused to assess the patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Group 1 propolis with lactic acid extract on top of the treatment given by doctor
propolis solved in lactic acid solvent
propolis given as a dietary supplement which was solved in a lactic acid solvent.
Amoxicillin-Clarithromycin-Lansoprazole
H pylori eradication treatment
Group 2
Grorup 2 Lactic acid extract on top of the treatment by the doctor
Amoxicillin-Clarithromycin-Lansoprazole
H pylori eradication treatment
Lactic acid
given to determine if the improvement of the symptoms are due to propolis or the solvent
Group 3
Group 3 the treatment given by the doctor and placebo treatment
Amoxicillin-Clarithromycin-Lansoprazole
H pylori eradication treatment
IV saline 0.9%
Physiological serum solution is given as a placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
propolis solved in lactic acid solvent
propolis given as a dietary supplement which was solved in a lactic acid solvent.
Amoxicillin-Clarithromycin-Lansoprazole
H pylori eradication treatment
IV saline 0.9%
Physiological serum solution is given as a placebo
Lactic acid
given to determine if the improvement of the symptoms are due to propolis or the solvent
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Apipark Beekeeping
UNKNOWN
Fatma Zehra Arvas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma Zehra Arvas
dietitian
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Related Links
Access external resources that provide additional context or updates about the study.
Propolis polyphenolic compounds affect the viability and structure of Helicobacter pylori in vitro
CHARACTERIZATION OF Helicobacter pylori, RESEARCH OF INHIBITION EFFECTS OF HONEY AND PROPOLIS SAMPLES ON BACTERIA AND UREASE
Reliability and Validity of the Turkish Version of the Gastrointestinal Symptom Rating Scale
The Effect of Propolis as a Functional Product on Health
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-77979112-424.04.01-82
Identifier Type: -
Identifier Source: org_study_id